In Re Blue Cross Blue Shield Antitrust Litigation MDL 2406

This multidistrict litigation consolidated class action claims that the Blue Cross Blue Shield Association and its member plans conspired to geographically divide markets, suppress competition, and inflate premiums, violating Section 1 of the Sherman Act. A historic $2.67 billion settlement was initially reached in 2020 and approved in 2022, but the Eleventh Circuit overturned the approval in 2024, citing errors in class certification and the allocation of settlement funds. On February 26, 2025, the district court held a status conference and ordered the parties to negotiate a revised settlement that addresses the appellate concerns. The case remains a landmark challenge to exclusive service area rules in the health insurance industry.

On February 26, 2025, the court issued an order directing the parties to submit a revised settlement plan, denying final approval of the prior agreement. The original $2.67 billion settlement remained vacated pending a new proposal that satisfies the appellate ruling on class structure and fund distribution.

Whether the BCBSA and its member plans engaged in an unlawful horizontal market allocation by agreeing to exclusive service areas, thereby reducing competition and raising premiums in violation of antitrust laws, and whether the proposed settlement adequately remedies the harm to different classes of subscribers.

The litigation has profoundly impacted the health insurance sector by exposing anticompetitive market divisions. It is expected to dismantle long-standing territorial restrictions among Blue plans, enhance market competition, and potentially lower premiums for millions of subscribers. The case also serves as a precedent for future antitrust challenges in the healthcare industry.